跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 155 条关于
“ANVIMO”
全部
155
临床试验
75
药物
48
机构
4
资讯
28
去年
Zydus Launches ANVIMO: Game-Changing CMV Prevention Drug for Transplant Patients at 91% Lower Cost
8个月前
Oncodesign Precision Medicine and Navigo Proteins Terminate Radiotheranostics Collaboration
去年
Butantan Institute Seeks Approval in Brazil for Single-Dose Dengue Vaccine
去年
AbViro Initiates NIH-Backed Human Challenge Trial for Novel Dengue Therapy
去年
Benuvia Operations Secures ANVISA GMP Certification, Expanding Pharmaceutical Manufacturing Capabilities in Brazil
去年
Navigo Proteins and SCK CEN Partner to Advance Terbium-161 Based Radiotheranostics
7个月前
Naprod Life Sciences Secures ANVISA GMP Certification Renewal for Oncology Manufacturing Operations
7个月前
Rapid Dose Therapeutics Launches QuickStrip Medical Cannabis in Brazil Following ANVISA Approval
去年
OneSource's Bengaluru Facility Secures ANVISA GMP Approval, Opening Doors to Brazilian Market
去年
Eris Lifesciences Receives ANVISA Approval for Sterile Injectable Facility, Enabling Brazil Market Entry
第 1 页,共 3 页
上一页
下一页